Levothyroxine Dose Adjustment
Increase her levothyroxine dose by 12.5 to 25 mcg daily (to 62.5-75 mcg daily) and recheck TSH in 6-8 weeks.
Rationale for Dose Adjustment
With a TSH of 8.44 mIU/L on levothyroxine 50 mcg daily, this 67-year-old woman has inadequately treated hypothyroidism requiring dose escalation. The AACE/ATA guidelines clearly state that increment changes of 12.5-25 mcg/day are initially made when adjusting levothyroxine doses 1. The FDA labeling confirms this approach, recommending titration by 12.5 to 25 mcg increments every 4 to 6 weeks until the patient is euthyroid 2.
Specific Dosing Recommendation
- Increase to 62.5 mcg daily (conservative 12.5 mcg increase) if she has any cardiac risk factors or symptoms
- Increase to 75 mcg daily (25 mcg increase) if she is otherwise healthy without cardiac concerns
The more aggressive 25 mcg increase is reasonable here since her TSH falls in the 8-12 mIU/L range, where guidelines suggest starting doses of 50 mcg for subclinical hypothyroidism 1. She's already on 50 mcg, so moving to 75 mcg is appropriate.
Age-Specific Considerations
At age 67, she falls into the elderly category where levothyroxine requirements are typically 20-25% lower per kilogram than younger patients due to decreased lean body mass 1. However, this doesn't mean avoiding dose increases when TSH is elevated—it means being more cautious with the rate of titration. Recent research confirms that older adults require approximately 1.09 mcg/kg actual body weight or 1.35 mcg/kg ideal body weight, which is one-third lower than the standard 1.6 mcg/kg used in younger populations 3.
Monitoring Timeline
Recheck TSH in 6-8 weeks after the dose adjustment 1, 2. While TSH levels may decline within a month with doses of 50-75 mcg, making adjustments with smaller doses may require 8 weeks or longer before TSH levels plateau 1. For elderly patients, the FDA specifically recommends titrating dosage every 6 to 8 weeks 2.
Critical Pitfalls to Avoid
1. Cardiac Screening
Before increasing the dose, assess for coronary heart disease or cardiac symptoms. If she has known CHD or develops anginal symptoms, titrate more slowly and monitor closely 1. The elderly are particularly susceptible to atrial fibrillation with overtreatment 1.
2. Medication Adherence
Before assuming malabsorption or increasing to very high doses, verify medication adherence—this is the most common cause of persistently elevated TSH 1. Ensure she's taking levothyroxine:
- On an empty stomach, 30-60 minutes before breakfast with water 1
- Not with interfering substances (calcium, iron, PPIs, etc.) 1
3. Avoid Overtreatment
The goal is TSH normalization, not suppression. Overtreatment carries cardiovascular and skeletal risks, particularly in postmenopausal women who are prone to accelerated bone loss 1. Target TSH should be within the normal reference range (generally 0.4-4.0 mIU/L), though some advocate for age-adjusted upper limits up to 7.5 mIU/L in patients over 80 4.
Alternative Consideration
If she has significant compliance issues that emerge during follow-up, weekly dosing of levothyroxine can be considered as it results in similar clinical outcomes and acceptable TSH values 1.